Digital devices useful in visual rehabilitation

Article

Digital devices may be used as a visual rehabilitation technique for low-vision AMD patients, according to a paper featured in the journal Eye.

Digital devices may be used as a visual rehabilitation technique for low-vision AMD patients, according to a paper featured in the journal Eye.

An investigation led by Dr K. Gill, Department of Ophthalmology, University of Western Ontario, London, Ontario, Canada, included 27 patients in the study. All patients had stable wet AMD in one or both eyes and were assessed for reading speeds on both digital readers and standard paper text.

The reading speed was calculated as words per minute and each patient completed the visual analogue scale after reading each passage. The patients read font sizes ranged from newsprint to large print books and then read from digital devices for comparison.

In conclusion, patients read faster on the Apple iPad with text sizes of 24 or more, compared to paper. Patients claimed the digital device has the best clarity but the print paper is the easiest to use.

Devices with larger display screens and high contrast ratios are beneficial to AMD patients who require larger texts for reading.

The abstract can be found here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.